Post-merger MSD To Begin Rollout Of Merck and Schering-Plough Legacy Products In Japan
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Merck, previously operating in Japan via majority-held Banyu Pharmaceutical, will merge with Schering-Plough Japan Oct. 1 under the new title MSD; the combined company expects to vault into the rankings of the top three pharmaceutical firms in Japan thanks to constant rollout of new products in the near-term future